An alginate-antacid formulation (Gaviscon Double Action Liquid) can eliminate or displace the postprandial ‘acid pocket’ in symptomatic GERD patients
Open Access
- 3 May 2011
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 34 (1), 59-66
- https://doi.org/10.1111/j.1365-2036.2011.04678.x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The efficacy of sodium alginate (Gaviscon) for the treatment of gastro-oesophageal reflux in preterm infantsAlimentary Pharmacology & Therapeutics, 2010
- Esophagogastric junction distensibility assessed with an endoscopic functional luminal imaging probe (EndoFLIP)Gastrointestinal Endoscopy, 2010
- Alginate–antacid combinations: raft formation and gastric retention studiesDrug Development and Industrial Pharmacy, 2009
- Liquid in the gastroesophageal segment promotes reflux, but compliance does not: a mathematical modeling studyAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2008
- Severe reflux disease is associated with an enlarged unbuffered proximal gastric acid pocketGut, 2008
- The suppression of gastro-oesophageal reflux by alginatesInternational Journal of Clinical Practice, 2007
- Clinical and laboratory studies of the antacid and raft‐forming properties of Rennie alginate suspensionAlimentary Pharmacology & Therapeutics, 2006
- Effect of Gaviscon Infant on gastro-oesophageal reflux in infants assessed by combined intraluminal impedance/pHArchives of Disease in Childhood, 2005
- Patterns of food and acid reflux in patients with low‐grade oesophagitis—the role of an anti‐reflux agentAlimentary Pharmacology & Therapeutics, 1998
- Alginic acid decreases postprandial upright gastroesophageal refluxDigestive Diseases and Sciences, 1992